Business Context and Reporting Period
This Form 8-K is a current report filed by Data Knights Acquisition Corp. (not OneMedNet Corp, which is the target of a proposed transaction) on October 13, 2023. The filing addresses a revision to the Proxy Card for a Special Meeting of Shareholders scheduled for October 17, 2023, regarding the proposed business combination with OneMedNet Corporation.
Key Financial Metrics
This filing is an informational report regarding corporate governance and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The material change reported is a correction of "scriveners' errors" on the Proxy Card previously distributed to shareholders. Specifically, the filing clarifies the nominees for the Class III director positions:
- Corrected Nominees: Dr. Jeffrey Yu and R. Scott Holbrook.
- Correction: Dr. Christoph Zindel is explicitly stated as not being a director nominee, correcting the previous Proxy Card.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the Proxy Statement (filed on September 21, 2023, and declared effective on September 22, 2023) remains the prevailing document for shareholder recommendations. The 8-K is strictly for informational purposes to resolve the clerical error.
Risks and Contingencies: The document includes standard legal disclaimers stating that this report is not a solicitation of proxies or an offer to sell securities. It notes that no sale of securities will occur in jurisdictions where such an offer would be unlawful without proper registration.
Investor Verification Checklist
- Verify the corrected list of Class III director nominees (Dr. Jeffrey Yu and R. Scott Holbrook) against the official Proxy Statement.
- Confirm the date and agenda of the Special Meeting scheduled for October 17, 2023.
- Review the full Proxy Statement (Form S-4) for detailed terms of the proposed transaction with OneMedNet Corporation.
- Check the company's Form 10-K for the fiscal year ended December 31, 2022, for information on participants in the proxy solicitation.